AAAAAA
Results: 1-25/27
Authors:
RIZVI NA
MARSHALL JL
NESS E
YEO J
GILL GM
TRUGLIA JA
LOEWEN GR
JAUNAKAIS D
ULM EH
HAWKINS MJ
Citation: Na. Rizvi et al., PHASE-I STUDY OF 9-CIS-RETINOIC ACID (ALRT1057 CAPSULES) IN ADULTS WITH ADVANCED CANCER, Clinical cancer research, 4(6), 1998, pp. 1437-1442
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, RECOVERING COBALT FROM PRIMARY AND SECONDARY SOURCES, JOM (1989), 50(10), 1998, pp. 46-50
Authors:
RIZVI NA
MARSHALL J
DAHUT W
HAWKINS MJ
Citation: Na. Rizvi et al., PHASE-I DOSE-ESCALATION AND SEQUENCING STUDY OF GEMCITABINE AND DOCETAXEL IN ADVANCED CANCERS, Annals of oncology, 9, 1998, pp. 629-629
Authors:
MARSHALL JL
DAHUT WL
RIZVI N
WAINER IW
CHASSAING C
FIGUIERA M
HAWKINS MJ
Citation: Jl. Marshall et al., PHASE-I TRIAL AND PHARMACOKINETIC (PK) ANALYSIS OF DEPSIPEPTIDE IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 472-472
Authors:
WOJTOWICZPRAGA S
TORRI J
JOHNSON M
STEEN V
MARSHALL J
NESS E
DICKSON R
SALE M
RASMUSSEN HS
CHIODO TA
HAWKINS MJ
Citation: S. Wojtowiczpraga et al., PHASE-I TRIAL OF MARIMASTAT, A NOVEL MATRIX METALLOPROTEINASE INHIBITOR, ADMINISTERED ORALLY TO PATIENTS WITH ADVANCED LUNG-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2150-2156
Authors:
HAWKINS WE
HAWKINS MJ
SABATINO C
LEY S
Citation: We. Hawkins et al., RELATIONSHIP OF PERCEIVED FUTURE OPPORTUNITY TO DEPRESSIVE SYMPTOMATOLOGY OF INNER-CITY AFRICAN-AMERICAN ADOLESCENTS, Children and youth services review, 20(9-10), 1998, pp. 757-764
Authors:
DALAKAS MC
MOCK V
HAWKINS MJ
Citation: Mc. Dalakas et al., FATIGUE - DEFINITIONS, MECHANISMS, AND PARADIGMS FOR STUDY, Seminars in oncology, 25(1), 1998, pp. 48-53
Authors:
HAWKINS WE
LATKIN C
HAWKINS MJ
CHOWDURY D
Citation: We. Hawkins et al., DEPRESSIVE SYMPTOMS AND HIV-RISK BEHAVIOR IN INNER-CITY USERS OF DRUGINJECTIONS, Psychological reports, 82(1), 1998, pp. 137-138
Authors:
MARSHALL JL
WELLSTEIN A
RAE J
DELAP RJ
PHIPPS K
HANFELT J
YUNMBAM MK
SUN JX
DUCHIN KL
HAWKINS MJ
Citation: Jl. Marshall et al., PHASE-I TRIAL OF ORALLY-ADMINISTERED PENTOSAN POLYSULFATE IN PATIENTSWITH ADVANCED CANCER, Clinical cancer research, 3(12), 1997, pp. 2347-2354
Authors:
POSEY J
VERMA U
DEO Y
MARSHALL JL
RASPET R
MAZUMDER A
HAWKINS MJ
Citation: J. Posey et al., PILOT TRIAL OF MDX-H210 AND GM-CSF FOR PATIENTS WITH ADVANCED ERBB-2 POSITIVE MALIGNANCIES, European journal of cancer, 33, 1997, pp. 122-122
Authors:
WOJTOWICZPRAGA SM
DICKSON RB
HAWKINS MJ
Citation: Sm. Wojtowiczpraga et al., MATRIX METALLOPROTEINASE INHIBITORS, Investigational new drugs, 15(1), 1997, pp. 61-75
Authors:
HAWKINS MJ
BREITMEYER JB
Citation: Mj. Hawkins et Jb. Breitmeyer, 1996 SOCIETY-FOR-BIOLOGICAL-THERAPY MEETING, Journal of immunotherapy with emphasis on tumor immunology, 19(6), 1996, pp. 452-455
Authors:
DICKSON RB
LOW JA
JOHNSON MD
HAWKINS MJ
TROCK BJ
Citation: Rb. Dickson et al., BLOOD-BORNE INDICATORS OF BREAST-CANCER AND THEIR USE IN EXPERIMENTAL, MEDICAL ONCOLOGIC, AND PREVENTION STUDIES, Breast, 5(5), 1996, pp. 379-384
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, COLLEGE-STUDENTS ATTITUDES TOWARD ELDERLY PERSONS, Educational gerontology, 22(3), 1996, pp. 271-279
Authors:
WOJTOWICZPRAGA S
LOW J
MARSHALL J
NESS E
DICKSON R
BARTER J
SALE M
MCCANN P
MOORE J
COLE A
HAWKINS MJ
Citation: S. Wojtowiczpraga et al., PHASE-I TRIAL OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR BATIMASTAT (BB-94) IN PATIENTS WITH ADVANCED CANCER, Investigational new drugs, 14(2), 1996, pp. 193-202
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, CLINICAL-TRIALS OF ANTI-ANGIOGENIC AGENTS, European journal of cancer, 31A, 1995, pp. 18-18
Authors:
MARSHALL JL
HAWKINS MJ
Citation: Jl. Marshall et Mj. Hawkins, THE CLINICAL-EXPERIENCE WITH ANTIANGIOGENIC AGENTS, Breast cancer research and treatment, 36(2), 1995, pp. 253-261
Authors:
HAWKINS MJ
GRAY C
HAWKINS WE
Citation: Mj. Hawkins et al., GENDER DIFFERENCES OF REPORTED SAFER SEX BEHAVIORS WITHIN A RANDOM SAMPLE OF COLLEGE-STUDENTS, Psychological reports, 77(3), 1995, pp. 963-968
Authors:
SPARANO JA
FISHER RI
WEISS GR
MARGOLIN K
ARONSON FR
HAWKINS MJ
ATKINS MB
DUTCHER JP
GAYNOR ER
BOLDT DH
DOROSHOW JH
ERNEST ML
SZNOL M
MIER JW
Citation: Ja. Sparano et al., PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 16(3), 1994, pp. 216-223
Authors:
HAWKINS MJ
ATKINS MB
DUTCHER JP
FISHER RI
WEISS GR
MARGOLIN KA
RAYNER AA
SZNOL M
PARKINSON DR
PAIETTA E
GAYNOR ER
BOLDT DH
DOROSHOW JH
ARONSON FR
Citation: Mj. Hawkins et al., A PHASE-II CLINICAL-TRIAL OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 74-78
Authors:
EARLY BP
HAWKINS MJ
Citation: Bp. Early et Mj. Hawkins, OPPORTUNITY AND RISKS IN EMERGING FAMILY POLICY - AN ANALYSIS OF FAMILY PRESERVATION LEGISLATION, Children and youth services review, 16(5-6), 1994, pp. 309-318
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, DURKHEIM ON OCCUPATIONAL CORPORATIONS - AN EXEGESIS AND INTERPRETATION, Journal of the history of ideas, 55(3), 1994, pp. 461-481
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, EARLY CANCER CLINICAL-TRIALS - SAFETY, NUMBERS, AND CONSENT, Journal of the National Cancer Institute, 85(20), 1993, pp. 1618-1619
Authors:
TRIMBLE EL
ADAMS JD
VENA D
HAWKINS MJ
FRIEDMAN MA
FISHERMAN JS
CHRISTIAN MC
CANETTA R
ONETTO N
HAYN R
ARBUCK SG
Citation: El. Trimble et al., PACLITAXEL FOR PLATINUM-REFRACTORY OVARIAN-CANCER - RESULTS FROM THE FIRST 1,000 PATIENTS REGISTERED TO NATIONAL-CANCER-INSTITUTE TREATMENT-REFERRAL-CENTER-9103, Journal of clinical oncology, 11(12), 1993, pp. 2405-2410
Authors:
HAWKINS MJ
Citation: Mj. Hawkins, INTERLEUKIN-2 ANTITUMOR AND EFFECTOR CELL RESPONSES, Seminars in oncology, 20(6), 1993, pp. 52-59